title: Low yearly completion rate of HDC investigations is a cause for concern.
authors: Stuart
authors: S
authors: McLennan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy*; D010349:Patient Compliance / Q000706:statistics & numerical data*; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents